NOX4 and diabetic kidney disease: Interestingly, NOX4 deletion or inhibition in a mouse model of diabetic nephropathy or NOX4 silencing in human podocytes markedly suppressed oxidative stress, inflammation, profibrotic factor expression, and enhanced podocyte marker expression.